Menu
Enrolling by invitation NCT06924515

The Application Value of Intercostal Suturing in Preventing Postoperative Thoracoscopic Lung Resection Chest Wall Pulmonary Hernia

No phase Interventional VATS Lung Hernia

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Intercostal suture.
Who it may be relevant to
Registry conditions: VATS, Lung Hernia. Basic parameters: from 18 years · Male.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The purpose of this trial is to understand whether intercostal suture can effectively prevent postoperative chest wall lung herniation, mainly to verify the following questions Can intercostal suture reduce postoperative chest wall lung herniation The hemostatic effect and hemostatic time of intercostal suture on intercostal muscle incision bleeding during surgery The researchers will divide the participants into two groups, one group will receive intercostal suture, and the other group will not receive intercostal suture, that is, conventional suture The participants will Receive or not receive intercostal suture during surgery Hemostatic effect and hemostasis time of rib intermuscular incision bleeding during surgery Chest CT will be reviewed 3 months after surgery to observe the chest wall incision

Interventions

  • Procedure Intercostal suture
    止血完成后使用结扎缝合引线器夹持1-0规格的PDS可吸收缝线在主操作口的头侧上一肋间穿入,于副操作空使用双关节分离钳在胸腔内抓持缝线后将缝线从结扎缝合引线器脱离,此时在主操作口足侧下一肋间穿入结扎缝合引线器,在胸腔内由分离钳夹持缝线经结扎缝合引线器钩爪夹持后将缝线牵拉出胸腔外,以此依次行连续缝合共5次缝合引线操作后拉拢缝线将主操作口闭合,打结结束缝合完成肋间肌及壁层胸膜的缝合。

Primary outcome measures

  • Postoperative chest CT at 3 months [Time frame: From enrollment to the end of treatment at 3 months]
  • Hemostasis time [Time frame: From enrollment to the end of surgery]
Secondary outcome measures (1)
  • Postoperative drainage volume within 3 days [Time frame: Postoperative Day 1,Day 2,Day 3]

Eligibility criteria

Inclusion criteria

  • Patients undergoing lung resection via multiport thoracoscopic surgery
  • Age greater than or equal to 18 years
  • No history of thoracic surgery

Exclusion criteria

  • Be converted to a thoracoscopic-assisted mini-thoracotomy,a rib retractor becomes necessary.
  • Be converted to thoracotomy or a conventional posterolateral incision may be necessary based on the specific intraoperative circumstances.
  • Uniportal thoracoscopic surgery
  • History of ipsilateral thoracic surgery

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Prevention

Study locations

China · 1 center
  • The First Affiliated Hospital of Chongqing Medical University — Chongqing

Identifiers

NCT: NCT06924515 · 2024-491-02

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗